Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study-Reference-Cited by-同舟云学术

Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study

Published:2024-01 Issue: Volume:67 Page:102367
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Wu Xu-Kun,Yang Lan-Fang,Chen Yu-Feng,Chen Zhong-Wu,Lu Hao,Shen Xue-Yi,Chi Min-Hui,Wang Liang,Zhang Hui,Chen Jia-Fei,Huang Jing-Yao,Zeng Yong-Yi,Yan Mao-Lin,Zhang Zhi-Bo

Funder

Fujian Medical University

Publisher

Elsevier BV

Subject

General Medicine

Reference42 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Management of hepatocellular carcinoma;J Hepatol,2018

3. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

4. Hepatocellular carcinoma;Forner;Lancet,2018

5. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J Hepatol,2022

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving treatment plan and mental health in children with abdominal infection for broad-spectrum bacterial infections;World Journal of Psychiatry;2024-09-19

2. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy;Current Treatment Options in Oncology;2024-09-11

3. Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study;International Immunopharmacology;2024-09

4. Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis;Frontiers in Immunology;2024-08-30

5. Recent developments in molecular targeted therapies for hepatocellular carcinoma in the genomic era;Expert Review of Molecular Diagnostics;2024-08-28